Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kloth

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Rehab Management|March 8, 1997
Wound care managementJ McCulloch, L Kloth
Critical Care Medicine|April 10, 2002
Very early extubation in children after cardiac surgeryRobin L Kloth, Victor C Baum
Physical Therapy|July 1, 1992
Chronic dermal ulcer healing enhanced with monophasic pulsed electrical stimulationJ Feedar, L Kloth, G Gentzkow
Journal of Cardiothoracic and Vascular Anesthesia|March 14, 2003
Preliminary experience with an endobronchial blocker designed for young childrenAaron B Parker, Paul J Hoehner, Robin L Kloth, et al.
Anesthesia and Analgesia|October 26, 2000
Small-dose droperidol effectively reduces nausea in a general surgical adult patient populationN S Kreisler, B F Spiekermann, C M Ascari, et al.
Clinical Pharmacokinetics|July 28, 2016
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib ExposureSander Bins, Karel Eechoute, Jacqueline S L Kloth, et al.
British Journal of Cancer|March 6, 2015
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitorsJ S L Kloth, A Pagani, M C Verboom, et al.
The Pharmacogenomics Journal|February 5, 2019
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumorsMichiel C Verboom, Jacqueline S L Kloth, Jesse J Swen, et al.
The Pharmacogenomics Journal|January 25, 2017
Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinibJ S L Kloth, M C Verboom, J J Swen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2016
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatmentJacqueline S L Kloth, Paul Hamberg, Pauline A J Mendelaar, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Rehab Management|March 8, 1997
Wound care managementJ McCulloch, L Kloth
Critical Care Medicine|April 10, 2002
Very early extubation in children after cardiac surgeryRobin L Kloth, Victor C Baum
Physical Therapy|July 1, 1992
Chronic dermal ulcer healing enhanced with monophasic pulsed electrical stimulationJ Feedar, L Kloth, G Gentzkow
Journal of Cardiothoracic and Vascular Anesthesia|March 14, 2003
Preliminary experience with an endobronchial blocker designed for young childrenAaron B Parker, Paul J Hoehner, Robin L Kloth, et al.
Anesthesia and Analgesia|October 26, 2000
Small-dose droperidol effectively reduces nausea in a general surgical adult patient populationN S Kreisler, B F Spiekermann, C M Ascari, et al.
Clinical Pharmacokinetics|July 28, 2016
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib ExposureSander Bins, Karel Eechoute, Jacqueline S L Kloth, et al.
British Journal of Cancer|March 6, 2015
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitorsJ S L Kloth, A Pagani, M C Verboom, et al.
The Pharmacogenomics Journal|February 5, 2019
Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumorsMichiel C Verboom, Jacqueline S L Kloth, Jesse J Swen, et al.
The Pharmacogenomics Journal|January 25, 2017
Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinibJ S L Kloth, M C Verboom, J J Swen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2016
Macrocytosis as a potential parameter associated with survival after tyrosine kinase inhibitor treatmentJacqueline S L Kloth, Paul Hamberg, Pauline A J Mendelaar, et al.
Pageof 2